Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma.
Kotaro SugawaraKoichi YagiYasuhiro OkumuraMasato NishidaSusumu AikouHiroharu YamashitaHideomi YamashitaYasuyuki SetoPublished in: International journal of clinical oncology (2019)
The multimodal treatment strategy combining dCRT and SALV is rational for treating cT4 ESCC patients. When curative resection is feasible, SALV can provide good long-term survival outcome for patients who responded to dCRT but did not achieve clinical CR with dCRT alone.
Keyphrases
- end stage renal disease
- prognostic factors
- rectal cancer
- locally advanced
- minimally invasive
- newly diagnosed
- ejection fraction
- chronic kidney disease
- computed tomography
- peritoneal dialysis
- stem cells
- squamous cell carcinoma
- mesenchymal stem cells
- radiation therapy
- patient reported outcomes
- bone marrow
- dual energy
- contrast enhanced
- patient reported